Skip to content
BioEngineering

BioEngineering

Tag: COVID-19

Hydroxychloroquine for SARS-CoV-2 treatment: useful or not?

Hydroxychloroquine or chloroquine is probably one of the most known drugs, that are widely used as a treatment for COVID-19. [...]

  • COVID-19
  • News
  • chloroquine
  •  
  • Coronavirus
  •  
  • COVID-19
  •  
  • hydroxychloroquine
Posted on May 25, 2020 by BioStr

Broad spectrum antiviral drugs against SARS-CoV-2 - which ones are useful?

COVID-19 pandemic brought a lot of interest to broad spectrum antiviral drugs, since the drug effective against some other viruses [...]

  • COVID-19
  • News
  • Coronavirus
  •  
  • COVID-19
  •  
  • drug
  •  
  • glycosphingolipid
Posted on May 23, 2020 by BioStr

New discoveries regarding T-cells role in anti-COVID-19 cell-mediated immunity

While most researches on COVID-19 nowadays are focusing on antibodies, it is also important to keep studying the role of [...]

  • COVID-19
  • News
  • Coronavirus
  •  
  • COVID-19
  •  
  • epitope
  •  
  • immunity
  •  
  • T-cell
Posted on May 22, 2020 by BioStr

Does COVID-19 infect blood vessels?

With time going by, more and more observations are made not only on COVID-19 viral pneumonia, but also on its [...]

  • COVID-19
  • News
  • ACE2
  •  
  • blood
  •  
  • Coronavirus
  •  
  • COVID-19
  •  
  • pericyte
  •  
  • vessel
Posted on May 20, 2020 by BioStr

Do positive PCR tests indicate the presence of anti-SARS-CoV-2 antibodies?

A lot of researches on COVID-19 are focusing on looking for anti-SARS-CoV-2 antibodies, but the percentage of infected people who [...]

  • COVID-19
  • News
  • antibody
  •  
  • COVID-19
  •  
  • IgG
  •  
  • PCR
Posted on May 14, 2020 by BioStr

Is there a way to predict severe respiratory failure in people with COVID-19?

It is well known now, that most people infected with SARS-CoV-2 experience low-degree fever or flu-like symptoms, but then severe [...]

  • COVID-19
  • News
  • COVID-19
  •  
  • predictor
  •  
  • SRF
  •  
  • suPAR
Posted on May 12, 2020 by BioStr

How does COVID-19 change and what role does recombination play in the changes?

Viruses change all the time, and COVID-19 isn't an exception. The most interesting changes come from S-protein mutations since most [...]

  • COVID-19
  • News
  • Coronavirus
  •  
  • COVID-19
  •  
  • D614G
  •  
  • recombination
  •  
  • S-protein
Posted on May 8, 2020 by BioStr

Llamas might be the source of the effective anti-COVID-19 antibodies

When looking for the possible treatments for SARS-CoV-2 scientists are looking for the most unusual sources. In the recent article scientists [...]

  • COVID-19
  • News
  • Uncategorized
  • antibody
  •  
  • Coronavirus
  •  
  • COVID-19
Posted on May 5, 2020 by BioStr

How does the number of antibodies and viral RNA in samples of infected people change over time?

There are a lot of unanswered questions about SARS-CoV-2, and one of them is about the dynamic of the infection. [...]

  • COVID-19
  • News
  • antibody
  •  
  • Coronavirus
  •  
  • COVID-19
  •  
  • IgG
  •  
  • IgM
  •  
  • RNA
Posted on April 30, 2020 by BioStr

Can cell-mediated immunity prevent people from being infected with COVID-19?

One of the biggest mystery of the COVID-19 pandemic is a very different variability of how heavy the virus hits [...]

  • COVID-19
  • News
  • Coronavirus
  •  
  • COVID-19
  •  
  • immunity
  •  
  • T-cell
Posted on April 29, 2020 by BioStr

Posts navigation

Older posts
Newer posts

About Author


Bioengineering student, science enthusiast

Search

Recent Posts

  • Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
  • Potential therapeutic targets for COVID-19 identified
  • COVID-19 and prothrombotic antiphospholipid antibodies - the correlation
  • SARS-CoV-2 mutation D614G: severity or infectivity?
  • SARS-CoV-2 infection gradient is found in the respiratory tract

Recent Comments

    Categories

    • COVID-19
    • News
    • Uncategorized

    © 2025 Greatis Software